# Innovation to augment the Polycystic Ovarian Syndrome Drugs Market
Author:  Pal Sinha, Barnali 
Author URL: https://financedigest.com/author/pal-sinha-barnali
Published: 2021-11-26
Category: Research Reports
Category URL: https://financedigest.com/category/research-reports
Meta Title: Global PCOS Drugs Market: Growth, Trends, and Forecast
Meta Description: Explore the potential growth opportunities in the global PCOS drugs market with key insights on drivers impacting market trends and revenue projections.
URL: https://financedigest.com/innovation-to-augment-the-polycystic-ovarian-syndrome-drugs-markethtml

![undefined](https://prod.superblogcdn.com/site_cuid_cm5qst7v3003gwirgwqtxn8i8/images/research-report-2-1736836874167-compressed.jpg)

The Polycystic Ovarian Syndrome Drugs Market is likely to mark stellar growth in the upcoming period. The current situation calls for conducive integrated healthcare models that do away with middlemen regarding offering various products and services. Drug manufacturers, hospital systems, PBMs (pharmacy benefit managers), wholesale distributors, hospital systems, medical [insurers](https://www.financedigest.com/different-countries-different-insurance-cultures-how-insurers-can-adapt-their-products.html "insurers"), and retail pharmacy outlets – are all into the integration of healthcare strategies. This would be how the healthcare vertical function in the upcoming period.

**Get Sample Copy of this Report@** [**https://www.persistencemarketresearch.com/samples/3682**](https://www.persistencemarketresearch.com/samples/3682)

According to the latest [market](https://www.financedigest.com/the-peptic-ulcer-drugs-market-to-proliferate-with-digitized-upswing.html "The Peptic Ulcer Drugs Market to proliferate with digitized upswing") report published by Persistence Market Research titled ‘ **Polycystic Ovary Syndrome Drugs Market: Global Industry Analysis and Forecast, 2016–2024**’, the global polycystic ovary syndrome drugs market is expected to register a **CAGR of 4.6%** during the forecast period 2016–2024 and is expected to expand **1.5x** in terms of revenue by 2024. The report analyzes the global [**PCOS drugs market**](http://www.persistencemarketresearch.com/market-research/polycystic-ovarian-syndrome-drugs-market.asp) performance and provides information on key drivers and trends likely to impact the market during the forecast period.

**Company Profiles:**

- Sanofi
- Novartis AG
- Teva Pharmaceutical Industries Limited
- Addex Therapeutics Ltd.
- BIOCAD
- Merck KGaA
- AstraZeneca plc.
- [Bristol Myers](https://www.financedigest.com/bristol-myers-pfizer-abbvie-drugs-likely-to-face-u-s-price-negotiation.html "Bristol Myers, Pfizer, AbbVie drugs likely to face U.S. price negotiation") Squibb Co.
- Ferring Pharmaceuticals, Inc.
- Crinetics Pharmaceuticals, Inc.
- Others

**Request for Methodology@** [**https://www.persistencemarketresearch.com/methodology/3682**](https://www.persistencemarketresearch.com/methodology/3682)

Growth of the global polycystic ovary syndrome [drugs market is mainly driven by increasing](https://www.financedigest.com/increasing-incidences-of-spinal-fractures-to-drive-the-osteoporosis-drugs-market.html "Increasing incidences of spinal fractures to drive the Osteoporosis Drugs Market") prevalence of the disease and a growing awareness among the patient population. Increasing purchasing power among people and rising awareness of PCOS are factors expected to [drive growth of the global PCOS drugs market](https://www.financedigest.com/innovation-based-discernment-to-drive-the-soybean-by-products-market.html "Innovation-Based Discernment To Drive The Soybean By-products Market"). The need for effective management of diseases associated with PCOS such as hirsutism, obesity, and infertility is likely to [boost the demand for PCOS drugs](https://www.financedigest.com/astrazeneca-lifts-2022-earnings-outlook-as-cancer-drugs-boost-results.html "AstraZeneca lifts 2022 earnings outlook as cancer drugs boost results"). Also, a growing popularity of combination drugs and their [rising adoption among the patient population is expected to boost revenue](https://www.financedigest.com/soccer-european-revenues-rise-10-in-2020-21-despite-covid.html "Soccer-European revenues rise 10% in 2020-21 despite COVID") growth of the PCOS drugs market in the coming years. A rising expenditure on research and development activities and introduction of novel drugs is further expected to boost [growth of the global polycystic ovary syndrome drugs market](https://www.financedigest.com/the-dry-eye-syndrome-treatment-market-to-have-growth-devised-on-innovation.html "The Dry Eye Syndrome Treatment Market to have growth devised on innovation") over the forecast period. However, lack of FDA approved drugs, a low level of awareness of PCOS in underdeveloped countries, and increasing [side effects associated with generics might hamper market](https://www.financedigest.com/analysis-ecb-seen-struggling-to-keep-market-on-side-after-mixed-messages.html "Analysis-ECB seen struggling to keep market on side after mixed messages") growth during the forecast period.

The global market for PCOS drugs presents several [growth](https://www.financedigest.com/innovative-apps-to-foster-the-growth-of-autogenous-vaccine-for-aquaculture-market.html "Innovative apps to foster the growth of Autogenous Vaccine For Aquaculture Market") opportunities for market players. There is a good growth potential in emerging markets and pharmaceutical drugs [manufacturers are focusing on emerging economies in the Asia Pacific and Africa](https://www.financedigest.com/can-private-equity-do-for-africas-manufacturers-what-its-done-for-f1-and-rugby.html "Can private equity do for Africa’s manufacturers what it’s done for F1 and rugby?") such as Kenya, Nigeria, etc. to target a large patient population. Also, effective reimbursement policies and reduction in the costs of drugs used for the treatment of PCOS is likely to increase the adoption of PCOS drugs across the globe. Leading market players are also [investing significantly in developing new branded](https://www.financedigest.com/5-compelling-reasons-that-you-should-invest-in-branding.html "5 Compelling Reasons That You Should Invest In Branding") drugs to treat PCOS, owing to an anticipated high rise in the global patient population. The demand for branded PCOS drugs is likely to increase significantly during the forecast period.

The global PCOS drugs [market is segmented based on Drug Class into Oral](https://www.financedigest.com/digitized-exclusivity-to-be-the-epicenter-of-oral-macromolecular-formulations-market.html "Digitized Exclusivity to be the epicenter of Oral Macromolecular Formulations Market") Contraceptives, Insulin Sensitizing Agents, Anti-Depressants, Ornithine Decarboxylase Inhibitors, Aromatase Inhibitors, and Diuretics. The contraceptive drug class segment is projected to [register a CAGR](https://www.financedigest.com/photonic-sensors-detectors-market-to-register-a-cagr-of-7-2.html "Photonic Sensors & Detectors Market to register a CAGR of 7.2%") of 5.4% over the forecast period. Oral contraceptives are generally the preferred first line therapy for the treatment of PCOS as they are easily available as OTC drugs. The insulin sensitizing agent segment is expected to register a [CAGR of 4.8% over the forecast period](https://www.financedigest.com/air-transport-mro-market-to-reach-us-72-6-bn-in-2021-is-poised-to-exhibit-a-4-8-cagr-during-the-assessment-period-2021-2031.html "Air Transport MRO Market to reach US$ 72.6 Bn in 2021, is poised to exhibit a 4.8% CAGR during the assessment period 2021 – 2031"). About 70% of PCOS patients are overweight and are in the category of possible candidates for type 2 diabetes. As a result, insulin sensitizing agents are the widely prescribed drugs for the treatment of PCOS today. In terms of value, the oral contraceptives and insulin sensitizing agents drug class segments are collectively expected to remain the dominant and most attractive segments over the forecast period.

The global PCOS drugs [market is segmented based on Distribution Channel into Hospital](https://www.financedigest.com/cyclic-innovation-to-drive-the-hospital-acquired-infection-control-market.html "Cyclic innovation to drive the Hospital Acquired Infection Control Market") Pharmacies, Drug Stores/OTC, E-Commerce, and Fertility Clinics. The hospital pharmacies segment is likely to lead the global PCOS drugs [market in terms of revenue growth](https://www.financedigest.com/agar-market-is-set-to-experience-revolutionary-growth-by-2026.html "Agar Market Is Set to Experience Revolutionary Growth by 2026") and is estimated to be valued at US$ 575.4 Mn by the end of 2024. In terms of value, the drugs stores/OTC segment is estimated to account for 27.0% share of the overall market by the end of 2016.

**Access Full Report@** [**https://www.persistencemarketresearch.com/checkout/3682**](https://www.persistencemarketresearch.com/checkout/3682)

On the basis of region, the market has been segmented into North America, Latin America, Europe, Asia Pacific, and the MEA. The North America market is expected to emerge as the dominant market for polycystic ovary syndrome drugs owing to a high diagnosis [rate and increasing](https://www.financedigest.com/rci-bank-increases-easy-access-interest-rate-to-1-02.html "Rci Bank Increases Easy Access Interest Rate To 1.02%") adoption of prescription drugs. North America is estimated to dominate the PCOS drugs market with maximum value share of the overall market by the end of 2016. The presence of well-established pharmaceutical companies in North America as well as a relatively high instance of patients being diagnosed in hospitals for PCOS is a major driver for [market growth](https://www.financedigest.com/carica-papaya-seed-oil-market-2022-present-scenario-and-growth-prospects-2027.html "Carica Papaya Seed Oil Market 2022 | Present Scenario and Growth Prospects 2027"). The [market in the Asia Pacific region is expected to register the highest CAGR](https://www.financedigest.com/augmented-reality-and-virtual-reality-market-to-register-a-cagr-of-42-2.html "Augmented Reality and Virtual Reality Market to register a CAGR of 42.2% ") of 5.5% over the forecast period. Significant increase in healthcare services [spending along with rapid economic](https://www.financedigest.com/infosecurity-europe-agenda-spotlights-innovation-as-security-leaders-address-cybersecurity-spend-in-the-face-of-economic-headwinds.html "Infosecurity Europe agenda spotlights innovation as security leaders address cybersecurity spend in the face of economic headwinds") growth and increasing awareness about health issues are some of the key factors likely to push the sales of PCOS drugs in the APAC market.

**Related Reports:**

[**Alopecia Treatment Market**](https://www.persistencemarketresearch.com/market-research/alopecia-treatment-market.asp)

[**Next Generation Antibody Therapeutics Market**](https://www.persistencemarketresearch.com/market-research/next-generation-antibody-therapeutics-market.asp)

**About Us:** [**Persistence Market Research**](https://www.persistencemarketresearch.com/about-us.asp)

**Contact Us:**

**Persistence Market Research**

Address – 305 Broadway, 7th Floor, New York City,

NY 10007 United States

U.S. Ph. – +1-646-568-7751

USA-Canada Toll-free – +1 800-961-0353

**Japan Office:** 1-2-1 Kinshi Arca [Central Building](https://www.financedigest.com/bosch-to-build-215-million-plant-in-central-mexico.html "Bosch to build 5 million plant in central Mexico")

14/F Tokyo, 130-0013, Japan

Call 1-888-863-3700

**Sales** – sales@persistencemarketresearch.com

**Website** – [https://www.persistencemarketresearch.com](https://www.persistencemarketresearch.com/)


---
This blog is powered by Superblog. Visit https://superblog.ai to know more.
---